Acarix AB (publ) today announced that the company has received feedback
from the German authorities, the Federal Joint Committee, G-BA, on its submission for reimbursement of the CADScor®System in Germany.





About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.